WASHINGTON, DC – OCTOBER 3, 2018 – The Weinberg Group (now ProPharma Group), is growing. In addition to people, the company has also expanded its capabilities. Building upon its role as the most...
WASHINGTON, DC – April 17, 2018 – Matthew Weinberg, Chief Executive Officer of The Weinberg Group Inc., will be speaking at the International Association for the Protection of Intellectual Property’s...
WASHINGTON, DC – November 30, 2017 – The Weinberg Group Inc., a Washington, DC, based FDA consulting firm, today released a list of 21 charitable organizations that the firm contributed to on...
WASHINGTON, DC – July 26, 2017 – Building STEPS, a Baltimore-based nonprofit that helps minority and underprivileged high school students pursue careers in the fields of science and technology, was...
The Weinberg Group, the leading FDA consultancy, is excited to announce the addition of Paul Eichholz to our leadership team. As Senior Vice President, Quality and Compliance, with oversight of all...
The Weinberg Group (now ProPharma Group), the leading FDA consulting firm, is pleased to announce that Steve Jensen has joined us as Senior Vice President, Head of Regulatory Consulting. Steve has...
FDANews Drug Industry Daily Nov. 21, 2014 Europe’s drug regulatory agency has revised the conflict of interest policy for its scientific committee members and experts, a move that one attorney says...
CEO Matthew Weinberg writes for Tobacco Reporter Magazine encouraging stakeholders to take advantage of the opportunity to respond to FDA e-cigarette regulations.
For more information on The Weinberg Group’s independent clinical auditing services, please contact Jeff Antos at jeff.antos@weinberggroup.com or 202.280.0815.
RALEIGH, NC, December 6, 2023 – ProPharma Group (ProPharma), the world’s largest Research Consulting Organization (RCO) and the leading global provider of regulatory, clinical and compliance services...
RALEIGH, NC, April 3, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry and a portfolio company of Odyssey...
ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of Diamond Pharma Services. Diamond Pharma Services provides regulatory affairs, pharmacovigilance, and...
$50m investment and rebrand unveiled at J.P. Morgan Healthcare Conference as part of new global growth strategy. RALEIGH, NC, January 9, 2023: ProPharma Group – the end-to-end, global provider of...
ProPharma Group - the end-to-end, global provider of regulatory, clinical and compliance services for the pharmaceutical, biotechnology and medical device industries launched the Research Consulting...